Childhood HIV-associated nephropathy: 36 years later.

Pediatr Nephrol

Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, 20010, USA.

Published: August 2021

HIV-associated nephropathy (HIVAN) predominantly affects people of African ancestry living with HIV who do not receive appropriate antiretroviral therapy (ART). Childhood HIVAN is characterized by heavy proteinuria and decreased kidney function. Kidney histology shows mesangial expansion, classic or collapsing glomerulosclerosis, and microcystic renal tubular dilatation leading to kidney enlargement. The pathogenesis of HIVAN involves the kidney recruitment of inflammatory cells and the infection of kidney epithelial cells. In addition, both viral and genetic factors play key roles in this disease. Modern ART has improved the outcome and decreased the prevalence of childhood HIVAN. However, physicians have had modest success providing chronic ART to children and adolescents, and we continue to see children with HIVAN all over the world. This article discusses the progress made during the last decade in our understanding of the pathogenesis and treatment of childhood HIVAN, placing particular emphasis on the mechanisms that mediate the infection of kidney epithelial cells, and the roles of cytokines, the HIV-Tat gene, and the Apolipoprotein-1 (APOL1) gene risk variants in this disease. In view of the large number of children living with HIV at risk of developing HIVAN, better prevention and treatment programs are needed to eradicate this disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061423PMC
http://dx.doi.org/10.1007/s00467-020-04756-4DOI Listing

Publication Analysis

Top Keywords

childhood hivan
12
hiv-associated nephropathy
8
living hiv
8
infection kidney
8
kidney epithelial
8
epithelial cells
8
hivan
7
kidney
6
childhood
4
childhood hiv-associated
4

Similar Publications

Article Synopsis
  • HIV-associated nephropathy (HIVAN) primarily affects individuals of African descent with high HIV-1 viral loads, and while antiretroviral therapies (ART) have improved outcomes, treating children and adolescents with HIV (CALWH) remains a significant challenge worldwide.
  • Over 2.5 million CALWH are at high risk for developing HIVAN, and existing research on the disease largely stems from studies on transgenic mice and adults, highlighting potential differences in risk factors and health outcomes for younger patients.
  • The article discusses advancements in understanding HIVAN's pathogenesis over the past 40 years, particularly the role of genetic factors like the APOL1 gene, and emphasizes the need for further research on renal inflammation, the
View Article and Find Full Text PDF

Circulating fibroblast growth factor-2 precipitates HIV nephropathy in mice.

Dis Model Mech

July 2021

Child Health Research Center, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

People of African ancestry living with the human immunodeficiency virus-1 (HIV-1) are at risk of developing HIV-associated nephropathy (HIVAN). Children with HIVAN frequently show high plasma fibroblast growth factor-2 (FGF-2) levels; however, the role of circulating FGF-2 in the pathogenesis of childhood HIVAN is unclear. Here, we explored how circulating FGF-2 affected the outcome of HIVAN in young HIV-Tg26 mice.

View Article and Find Full Text PDF

Childhood HIV-associated nephropathy: 36 years later.

Pediatr Nephrol

August 2021

Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, 20010, USA.

HIV-associated nephropathy (HIVAN) predominantly affects people of African ancestry living with HIV who do not receive appropriate antiretroviral therapy (ART). Childhood HIVAN is characterized by heavy proteinuria and decreased kidney function. Kidney histology shows mesangial expansion, classic or collapsing glomerulosclerosis, and microcystic renal tubular dilatation leading to kidney enlargement.

View Article and Find Full Text PDF

An HIV-Tat inducible mouse model system of childhood HIV-associated nephropathy.

Dis Model Mech

October 2020

Child Health Research Center, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA

Modern antiretroviral therapies (ART) have decreased the prevalence of HIV-associated nephropathy (HIVAN). Nonetheless, we continue to see children and adolescents with HIVAN all over the world. Furthermore, once HIVAN is established in children, it is difficult to revert its long-term progression, and we need better animal models of childhood HIVAN to test new treatments.

View Article and Find Full Text PDF

Tuberculosis and HIV-An Update on the "Cursed Duet" in Children.

Front Pediatr

April 2019

Family Centre for Research with Ubuntu (FAM-CRU), Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.

HIV and tuberculosis (TB) often occur together with each exacerbating the other. Improvements in vertical transmission prevention has reduced the number of HIV-infected children being born and early antiretroviral therapy (ART) protects against tuberculosis. However, with delayed HIV diagnosis, HIV-infected infants often present with tuberculosis co-infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!